New section in journal of translational medicine: patient-targeted molecular therapies

<p>Abstract</p> <p>This Editorial announces a new section in the Journal of Translational Medicine: Patient-Targeted Molecular Therapies. This section is dedicated to the dissemination of targeted molecular therapies in context of patient-centered outcomes research and evidence-bas...

Full description

Bibliographic Details
Main Authors: Bot Adrian, Chiappelli Francesco
Format: Article
Language:English
Published: BMC 2012-05-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/10/1/92
id doaj-6f370adbe6b045daa545200e6a8e1cbb
record_format Article
spelling doaj-6f370adbe6b045daa545200e6a8e1cbb2020-11-25T00:29:20ZengBMCJournal of Translational Medicine1479-58762012-05-011019210.1186/1479-5876-10-92New section in journal of translational medicine: patient-targeted molecular therapiesBot AdrianChiappelli Francesco<p>Abstract</p> <p>This Editorial announces a new section in the Journal of Translational Medicine: Patient-Targeted Molecular Therapies. This section is dedicated to the dissemination of targeted molecular therapies in context of patient-centered outcomes research and evidence-based clinical decisions. The focus on patient-targeted molecular therapies – spanning small molecules and biomolecules alike – stems from the unprecedented growth in this arena. This is consonant with the overall objective of the Journal of Translational Medicine, which seeks out to expand firmly to other vast areas of medicine in the domain of translational science, viewed here as the transaction between translational research and translational effectiveness. As we inaugurate this new section in Journal of Translational Medicine, with its mission described in detail in this Editorial, we invite interested scientists to submit their work for publication.</p> http://www.translational-medicine.com/content/10/1/92
collection DOAJ
language English
format Article
sources DOAJ
author Bot Adrian
Chiappelli Francesco
spellingShingle Bot Adrian
Chiappelli Francesco
New section in journal of translational medicine: patient-targeted molecular therapies
Journal of Translational Medicine
author_facet Bot Adrian
Chiappelli Francesco
author_sort Bot Adrian
title New section in journal of translational medicine: patient-targeted molecular therapies
title_short New section in journal of translational medicine: patient-targeted molecular therapies
title_full New section in journal of translational medicine: patient-targeted molecular therapies
title_fullStr New section in journal of translational medicine: patient-targeted molecular therapies
title_full_unstemmed New section in journal of translational medicine: patient-targeted molecular therapies
title_sort new section in journal of translational medicine: patient-targeted molecular therapies
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2012-05-01
description <p>Abstract</p> <p>This Editorial announces a new section in the Journal of Translational Medicine: Patient-Targeted Molecular Therapies. This section is dedicated to the dissemination of targeted molecular therapies in context of patient-centered outcomes research and evidence-based clinical decisions. The focus on patient-targeted molecular therapies – spanning small molecules and biomolecules alike – stems from the unprecedented growth in this arena. This is consonant with the overall objective of the Journal of Translational Medicine, which seeks out to expand firmly to other vast areas of medicine in the domain of translational science, viewed here as the transaction between translational research and translational effectiveness. As we inaugurate this new section in Journal of Translational Medicine, with its mission described in detail in this Editorial, we invite interested scientists to submit their work for publication.</p>
url http://www.translational-medicine.com/content/10/1/92
work_keys_str_mv AT botadrian newsectioninjournaloftranslationalmedicinepatienttargetedmoleculartherapies
AT chiappellifrancesco newsectioninjournaloftranslationalmedicinepatienttargetedmoleculartherapies
_version_ 1725331876644651008